Tobisu K, Kakizoe T, Takai K, Tanaka Y
Department of Urology, National Cancer Center Hospital, Tokyo.
Jpn J Clin Oncol. 1989 Jun;19(2):142-8.
The clinical courses and survivals of 159 patients who underwent nephrectomy for renal cell carcinoma are reviewed. A longer disease-free period after nephrectomy was correlated with significantly better survival. Among patients in whom metastases in the lungs or bones were detected after nephrectomy, those with between one and five pulmonary or solitary bone metastases, without definite increases in their number and size in the six months following their first appearance, survived significantly longer than patients with a similar number of metastases but which did increase in number and size in the following six months, or patients with six or more pulmonary or multiple bone metastases. Even when metastases detected after nephrectomy were confined to the lungs or bones throughout the observation period, the patients did not necessarily show significantly better survivals than patients with metastases detected in multiple sites.
回顾了159例行肾细胞癌肾切除术患者的临床病程及生存情况。肾切除术后较长的无病生存期与显著更好的生存率相关。在肾切除术后检测到肺部或骨转移的患者中,那些有1至5个肺转移或孤立骨转移且在首次出现后的6个月内数量和大小无明显增加的患者,其生存期明显长于有相似转移数量但在接下来的6个月内数量和大小增加的患者,或有6个或更多肺转移或多发骨转移的患者。即使在整个观察期内肾切除术后检测到的转移局限于肺部或骨骼,这些患者的生存率也不一定显著高于在多个部位检测到转移的患者。